Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection

Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection

Abstract Background Recombinant insulin Lisargine is a new type of insulin. In this study, we aimed to compare its pharmacodynamic (PD) and pharmacokinetic (PK) with Lantus. Methods The PD test was performed by exploring the effect of single administration on blood glucose of normal rats and STZ-ind...

Full description

Bibliographic Details
Main Authors: Jiangjie Lu, Yong Zeng, Xiulin Yi, Hongmei Zhang, Lin Zhu, Lixin Jiang, Jing Li, Wei Zhou, Hong Zhu, Aijun Xiong
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Pharmacodynamic
Pharmacokinetic
Recombinant insulin Lisargine injection
Lantus
Online Access:http://link.springer.com/article/10.1186/s12906-020-03110-3

Internet

http://link.springer.com/article/10.1186/s12906-020-03110-3

Similar Items